ferric citrate
AssetAlso called Auryxia, ferric chloride, Fexeric
Binds dietary phosphate in the gastrointestinal tract, reducing phosphate absorption and serum phosphorus levels.
- Stage
- Approved
- Modality
- Small molecule
- Target
- Not known
- 15
- Indications
- 21
- Trials
- 5
- Developers
Approved by the FDA on Sep 5, 2014 (NDA205874). FDA
Indications
15Hyperphosphatemia in dialysis-dependent chronic kidney disease
Approved, SEC filing
Iron deficiency anemia in non-dialysis-dependent chronic kidney disease
Approved, SEC filing
Anemia in chronic kidney disease
Approved, FDA
12 more
In the full profile
- Target and mechanism1
- Owner and partners7
- Trials21
- Evidence for its targets2
- Competitors12
- Signals9
Every asset’s record: target, stage, trials and the evidence behind it.